Clinical Trials for Emergent BioSolutions

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Emergent BioSolutions

Clinical Trials (5)

NCT02177721
Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario
PHASE4Not yet recruiting
100 participants
Started: May 31, 2026 · Completed: Dec 31, 2035
1 condition3 sponsors0 locations
NCT03569553
A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients
N/ANot yet recruiting
100 participants
Started: May 30, 2026 · Completed: Jul 31, 2026
1 condition3 sponsors0 locations
NCT03569514
Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax
N/ANot yet recruiting
10 participants
Started: Nov 30, 2025 · Completed: Jul 31, 2026
1 condition3 sponsors0 locations
NCT02051062
BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients
PHASE4Enrolling by invitation
10 participants
Started: Oct 31, 2014 · Completed: Jul 31, 2027
1 condition1 sponsor0 locations
NCT01374984
VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection
N/AEnrolling by invitation
100 participants
Started: Aug 31, 2007 · Completed: Aug 31, 2027
1 condition2 sponsors0 locations